Increased risk for the development of preeclampsia in obese pregnancies: Weighing in on the mechanisms

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 309, Issue 11, 2015, Pages R1326-R1343

  Spradley, Frank T ^a   Palei, Ana C ^a   Granger, Joey P ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Body mass index; Inflammation; Placental ischemia; Pregnancy; RUPP; sFlt 1

Indexed keywords

ENDOTHELIN 1; GLUCOSE; INSULIN; LEPTIN; LIPID; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; ADIPOCYTOKINE; ANGIOGENIC PROTEIN; AUTACOID;

CELL MIGRATION; CYTOTROPHOBLAST; FEMALE; HUMAN; HYPOXIA; ISCHEMIA; NONHUMAN; OBESITY; PLACENTA FUNCTION; PLACENTA PERFUSION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; ANIMAL; BLOOD PRESSURE; COMPLICATION; METABOLISM; PATHOPHYSIOLOGY; PLACENTA; PLACENTA CIRCULATION; PRE-ECLAMPSIA; SIGNAL TRANSDUCTION; VASCULARIZATION;

ADIPOKINES; ANGIOGENIC PROTEINS; ANIMALS; BLOOD PRESSURE; FEMALE; HUMANS; INFLAMMATION MEDIATORS; ISCHEMIA; OBESITY; PLACENTA; PLACENTAL CIRCULATION; PRE-ECLAMPSIA; PREGNANCY; RISK ASSESSMENT; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84949210251     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00178.2015     Document Type: Review

References (201)

1. Ajne G, Nisell H, Jansson T. Effects of blockade of the endothelin receptor A and inhibition of nitric oxide synthesis on uteroplacental and renal blood flow in awake pregnant rats. Am J Obstet Gynecol 192: 295–301, 2005.
2. Akyol A, Langley-Evans SC, McMullen S. Obesity induced by cafeteria feeding and pregnancy outcome in the rat. Br J Nutr 102: 1601–1610, 2009.
3. Alexander BT, Cockrell KL, Massey MB, Bennett WA, Granger JP. Tumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression. Am J Hypertens 15: 170–175, 2002.
4. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 122: 1122–1131, 2013.
5. Athanassiades A, Hamilton GS, Lala PK. Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast. Biol Reprod 59: 643–654, 1998.
6. Aye IL, Waddell BJ, Mark PJ, Keelan JA. Oxysterols inhibit differentiation and fusion of term primary trophoblasts by activating liver X receptors. Placenta 32: 183–191, 2011.
7. Baptiste-Roberts K, Salafia CM, Nicholson WK, Duggan A, Wang NY, Brancati FL. Maternal risk factors for abnormal placental growth: the national collaborative perinatal project. BMC Pregnancy Childbirth 8: 44, 2008.
8. Barros JS, Bairos VA, Baptista MG, Fagulha JO. Immunocytochemical localization of endothelin-1 in human placenta from normal and preeclamptic pregnancies. Hypertens Pregnancy 20: 125–137, 2001.
9. Benirschke K. Remarkable placenta. Clin Anatomy 11: 194–205, 1998.
10. Benkhoff S, Loot AE, Pierson I, Sturza A, Kohlstedt K, Fleming I, Shimokawa H, Grisk O, Brandes RP, Schroder K. Leptin potentiates endothelium-dependent relaxation by inducing endothelial expression of neuronal NO synthase. Arterioscler Thromb Vasc Biol 32: 1605–1612, 2012.
11. Benyo DF, Miles TM, Conrad KP. Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab 82: 1582–1588, 1997.
12. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 86: 2505–2512, 2001.
13. Bhattacharya S, Campbell DM, Liston WA, Bhattacharya S. Effect of Body Mass Index on pregnancy outcomes in nulliparous women delivering singleton babies. BMC Public Health 7: 168, 2007.
14. Bodnar LM, Ness RB, Harger GF, Roberts JM. Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol 162: 1198–1206, 2005.
15. Bodnar LM, Ness RB, Markovic N, Roberts JM. The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol 15: 475–482, 2005.
16. Bridges JP, Gilbert JS, Colson D, Gilbert SA, Dukes MP, Ryan MJ, Granger JP. Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats. Am J Hypertens 22: 564–568, 2009.
17. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Ann 1: 177–191, 1972.
18. Bullo M, Garcia-Lorda P, Peinado-Onsurbe J, Hernandez M, Del Castillo D, Argiles JM, Salas-Salvado J. TNFalpha expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipocyte LPL activity and leptin synthesis. Int J Obes Relat Metab Disord 26: 652–658, 2002.
19. Bullo M, Garcia-Lorda P, Salas-Salvado J. Plasma soluble tumor necrosis factor alpha receptors and leptin levels in normal-weight and obese women: effect of adiposity and diabetes. Eur J Endocrinol 146: 325–331, 2002.
20. Bytautiene E, Tamayo E, Kechichian T, Drever N, Gamble P, Hankins GD, Saade GR. Prepregnancy obesity and sFlt1-induced preeclampsia in mice: developmental programming model of metabolic syndrome. Am J Obstet Gynecol 204: 398 e391-e398, 2011.
21. Cekmen MB, Erbagci AB, Balat A, Duman C, Maral H, Ergen K, Ozden M, Balat O, Kuskay S. Plasma lipid and lipoprotein concentrations in pregnancy induced hypertension. Clin Biochem 36: 575–578, 2003.
22. Cervar M, Kainer F, Desoye G. Pre-eclampsia and gestational age differently alter binding of endothelin-1 to placental and trophoblast membrane preparations. Molec Cell Endocrinol 110: 65–71, 1995.
23. Chacon MR, Miranda M, Jensen CH, Fernandez-Real JM, Vilarrasa N, Gutierrez C, Naf S, Gomez JM, Vendrell J. Human serum levels of fetal antigen 1 (FA1/Dlk1) increase with obesity, are negatively associated with insulin sensitivity and modulate inflammation in vitro. Int J Obes (Lond) 32: 1122–1129, 2008.
24. Challier JC, Basu S, Bintein T, Minium J, Hotmire K, Catalano PM, Hauguel-de Mouzon S. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 29: 274–281, 2008.
25. Chappell LC, Seed PT, Briley A, Kelly FJ, Hunt BJ, Charnock-Jones DS, Mallet AI, Poston L. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 187: 127–136, 2002.
26. Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, McKillop JH. Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol 104: 154–159, 1996.
27. Cho GJ, Roh GS, Kim HJ, Kim YS, Cho SH, Choi WJ, Paik WY, Kang SS, Choi WS. Differential expression of placenta growth factors and their receptors in the normal and pregnancy-induced hypertensive human placentas. J Korean Med Sci 18: 402–408, 2003.
28. Choi JW, Pai SH, Kim SK, Ito M, Park CS, Cha YN. Increases in nitric oxide concentrations correlate strongly with body fat in obese humans. Clin Chem 47: 1106–1109, 2001.
29. Cobellis L, Mastrogiacomo A, Federico E, Schettino MT, De Falco M, Manente L, Coppola G, Torella M, Colacurci N, De Luca A. Distribution of Notch protein members in normal and preeclampsia-complicated placentas. Cell Tissue Res 330: 527–534, 2007.
30. Cornelius DC, Wallace K, Scott JD, Campbell N, Thomas A, Hogg JP, Moseley J, LaMarca B. [35-OR]: A role for TH17 cells and IL-17 in mediating the pathophysiology associated with preeclampsia. Pregnancy Hypertens 5: 17, 2015.
31. Craici IM, Wagner SJ, Bailey KR, Fitz-Gibbon PD, Wood-Wentz CM, Turner ST, Hayman SR, White WM, Brost BC, Rose CH, Grande JP, Garovic VD. Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study. Hypertension 61: 1289–1296, 2013.
32. Cursio R, Miele C, Filippa N, Van Obberghen E, Gugenheim J. Liver HIF-1 alpha induction precedes apoptosis following normothermic ischemia-reperfusion in rats. Transplant Proc 40: 2042–2045, 2008.
33. D’Ippolito S, Tersigni C, Scambia G, Di Simone N. Adipokines, an adipose tissue and placental product with biological functions during pregnancy. Biofactors 38: 14–23, 2012.
34. da Silva AA, Kuo JJ, Tallam LS, Hall JE. Role of endothelin-1 in blood pressure regulation in a rat model of visceral obesity and hypertension. Hypertension 43: 383–387, 2004.
35. Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, Kolarz B, Rolinski J, Leszczynska-Gorzelak B, Oleszczuk J. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J Reprod Immunol 93: 75–81, 2012.
36. Davis JR, Giardina JB, Green GM, Alexander BT, Granger JP, Khalil RA. Reduced endothelial NO-cGMP vascular relaxation pathway during TNF-alpha-induced hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol 282: R390–R399, 2002.
37. de Grauw TJ, Myers RE, Scott WJ. Fetal growth retardation in rats from different levels of hypoxia. Biol Neonate 49: 85–89, 1986.
38. Dey M, Arora D, Narayan N, Kumar R. Serum cholesterol and ceruloplasmin levels in second trimester can predict development of pre-eclampsia. North Am J Medical Sci 5: 41–46, 2013.
39. Di Benedetto A, D’Anna R, Cannata ML, Giordano D, Interdonato ML, Corrado F. Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women. Diabetes Metab 38: 63–67, 2012.
40. Dietz PM, Callaghan WM, Sharma AJ. High pregnancy weight gain and risk of excessive fetal growth. Am J Obstet Gynecol 201: 51 e51–56, 2009.
41. Donato AJ, Henson GD, Morgan RG, Enz RA, Walker AE, Lesniewski LA. TNF-alpha impairs endothelial function in adipose tissue resistance arteries of mice with diet-induced obesity. Am J Physiol Heart Circ Physiol 303: H672–H679, 2012.
42. Dubova EA, Pavlov KA, Borovkova EI, Bayramova MA, Makarov IO, Shchegolev AI. Vascular endothelial growth factor and its receptors in the placenta of pregnant women with obesity. Bull Exp Biol Med 151: 253–258, 2011.
43. El-Chaar D, Finkelstein SA, Tu X, Fell DB, Gaudet L, Sylvain J, Tawagi G, Wen SW, Walker M. The impact of increasing obesity class on obstetrical outcomes. J Obstet Gynaecol Can 35: 224–233, 2013.
44. Endresen MJ, Tosti E, Heimli H, Lorentzen B, Henriksen T. Effects of free fatty acids found increased in women who develop pre-eclampsia on the ability of endothelial cells to produce prostacyclin, cGMP and inhibit platelet aggregation. Scand J Clin Lab Invest 54: 549–557, 1994.
45. Fabbrini E, deHaseth D, Deivanayagam S, Mohammed BS, Vitola BE, Klein S. Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content. Obesity (Silver Spring) 17: 25–29, 2009.
46. Ferraro ZM, Barrowman N, Prud’homme D, Walker M, Wen SW, Rodger M, Adamo KB. Excessive gestational weight gain predicts large for gestational age neonates independent of maternal body mass index. J Matern Fetal Neonatal Med 25: 538–542, 2012.
47. Fiore G, Capasso A. Effects of vitamin E and C on placental oxidative stress: an in vitro evidence for the potential therapeutic or prophylactic treatment of preeclampsia. Med Chem 4: 526–530, 2008.
48. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307: 491–497, 2012.
49. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303: 235–241, 2010.
50. Founds SA, Powers RW, Patrick TE, Ren D, Harger GF, Markovic N, Roberts JM. A comparison of circulating TNF-alpha in obese and lean women with and without preeclampsia. Hypertension Pregnancy 27: 39–48, 2008.
51. Frederick IO, Williams MA, Sales AE, Martin DP, Killien M. Pre-pregnancy body mass index, gestational weight gain, and other maternal characteristics in relation to infant birth weight. Matern Child Health J 12: 557–567, 2008.
52. Frias AE, Morgan TK, Evans AE, Rasanen J, Oh KY, Thornburg KL, Grove KL. Maternal high-fat diet disturbs uteroplacental hemodynamics and increases the frequency of stillbirth in a nonhuman primate model of excess nutrition. Endocrinology 152: 2456–2464, 2011.
53. Frohlich JD, Huppertz B, Abuja PM, Konig J, Desoye G. Oxygen modulates the response of first-trimester trophoblasts to hyperglycemia. Am J Pathol 180: 153–164, 2012.
54. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science 277: 1669–1672, 1997.
55. George EM, Colson D, Dixon J, Palei AC, Granger JP. Heme Oxygenase-1 Attenuates Hypoxia-Induced sFlt-1 and Oxidative Stress in Placental Villi through Its Metabolic Products CO and Bilirubin. Int J hypertens 2012: 486053, 2012.
56. Ghosh SK, Raheja S, Tuli A, Raghunandan C, Agarwal S. Serum placental growth factor as a predictor of early onset preeclampsia in overweight/obese pregnant women. J Am Soc Hypertens 7: 137–148, 2013.
57. Giardina JB, Green GM, Cockrell KL, Granger JP, Khalil RA. TNF-alpha enhances contraction and inhibits endothelial NO-cGMP relaxation in systemic vessels of pregnant rats. Am J Physiol Regul Integr Comp Physiol 283: R130–R143, 2002.
58. Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 50: 1142–1147, 2007.
59. Gilbert JS, Verzwyvelt J, Colson D, Arany M, Karumanchi SA, Granger JP. Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension. Hypertension 55: 380–385, 2010.
60. Gillis EE, Williams JM, Garrett MR, Mooney JN, Sasser JM. The Dahl salt sensitive rat is a spontaneous model of superimposed preeclampsia. Am J Physiol Regul Integr Comp Physiol 309: R62–R70, 2015.
61. Gonzalez-Perez RR, Xu Y, Guo S, Watters A, Zhou W, Leibovich SJ. Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkappaB/HIF-1alpha activation. Cell Signal 22: 1350–1362, 2010.
62. Gu P, Xu A. Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction. Rev Endocr Metab Disord 14: 49–58, 2013.
63. Gupte M, Thatcher SE, Boustany-Kari CM, Shoemaker R, Yiannikouris F, Zhang X, Karounos M, Cassis LA. Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice. Arterioscler Thromb Vasc Biol 32: 1392–1399, 2012.
64. Hayes EK, Lechowicz A, Petrik JJ, Storozhuk Y, Paez-Parent S, Dai Q, Samjoo IA, Mansell M, Gruslin A, Holloway AC, Raha S. Adverse fetal and neonatal outcomes associated with a life-long high fat diet: role of altered development of the placental vasculature. PLos One 7: e33370, 2012.
65. Hendler I, Blackwell SC, Mehta SH, Whitty JE, Russell E, Sorokin Y, Cotton DB. The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia. Am J Obstet Gynecol 193: 979–983, 2005.
66. Herse F, Fain JN, Janke J, Engeli S, Kuhn C, Frey N, Weich HA, Bergmann A, Kappert K, Karumanchi SA, Luft FC, Muller DN, Staff AC, Dechend R. Adipose tissue-derived soluble fms-like tyrosine kinase 1 is an obesity-relevant endogenous paracrine adipokine. Hypertension 58: 37–42, 2011.
67. Higgins L, Mills TA, Greenwood SL, Cowley EJ, Sibley CP, Jones RL. Maternal obesity and its effect on placental cell turnover. J Matern Fetal Neonatal Med 26: 783–788, 2013.
68. Hofmann AP, Gerber SA, Croy BA. Uterine natural killer cells pace early development of mouse decidua basalis. Mol Human Reproduct 20: 66–76, 2014.
69. Holdsworth-Carson SJ, Lim R, Mitton A, Whitehead C, Rice GE, Permezel M, Lappas M. Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia. Placenta 31: 222–229, 2010.
70. Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM. Fasting serum triglycerides, free fatty acids, and malondi-aldehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol 174: 975–982, 1996.
71. Hung TH, Burton GJ. Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol 45: 189–200, 2006.
72. Hung TH, Charnock-Jones DS, Skepper JN, Burton GJ. Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol 164: 1049–1061, 2004.
73. Hung TH, Chen SF, Liou JD, Hsu JJ, Li MJ, Yeh YL, Hsieh TT. Bax, Bak and mitochondrial oxidants are involved in hypoxia-reoxygenation-induced apoptosis in human placenta. Placenta 29: 565–583, 2008.
74. Hung TH, Skepper JN, Burton GJ. In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol 159: 1031–1043, 2001.
75. Hung TH, Skepper JN, Charnock-Jones DS, Burton GJ. Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res 90: 1274–1281, 2002.
76. Hunkapiller NM, Gasperowicz M, Kapidzic M, Plaks V, Maltepe E, Kitajewski J, Cross JC, Fisher SJ. A role for Notch signaling in trophoblast endovascular invasion and in the pathogenesis of pre-eclampsia. Development 138: 2987–2998, 2011.
77. Huppertz B, Weiss G, Moser G. Trophoblast invasion and oxygenation of the placenta: measurements versus presumptions. J Reprod Immunol 101–102: 74–79, 2014.
78. Jebelovszki E, Kiraly C, Erdei N, Feher A, Pasztor ET, Rutkai I, Forster T, Edes I, Koller A, Bagi Z. High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation. Am J Physiol Heart Circ Physiol 294: H2558–H2564, 2008.
79. Kakogawa J, Sumimoto K, Kawamura T, Minoura S, Kanayama N. Noninvasive monitoring of placental oxygenation by near-infrared spectroscopy. Am J Perinatol 27: 463–468, 2010.
80. Kakogawa J, Sumimoto K, Kawamura T, Minoura S, Kanayama N. Transabdominal measurement of placental oxygenation by near-infrared spectroscopy. Am J Perinatol 27: 25–29, 2010.
81. Kawamura T, Kakogawa J, Takeuchi Y, Takani S, Kimura S, Nishiguchi T, Sugimura M, Sumimoto K, Kanayama N. Measurement of placental oxygenation by transabdominal near-infrared spectroscopy. Am J Perinatol 24: 161–166, 2007.
82. Khamaisi M, Skarzinski G, Mekler J, Zreik F, Damouni R, Ariel I, Bursztyn M. Hyperinsulinemia increases placenta endothelin-converting enzyme-1 expression in trophoblasts. Am J Hypertens 25: 109–114, 2012.
83. Kiprono LV, Wallace K, Moseley J, Martin J Jr, Lamarca B. Progesterone blunts vascular endothelial cell secretion of endothelin-1 in response to placental ischemia. Am J Obstet Gynecol 209: 44 e41–46, 2013.
84. Kobayasi R, Akamine EH, Davel AP, Rodrigues MA, Carvalho CR, Rossoni LV. Oxidative stress and inflammatory mediators contribute to endothelial dysfunction in high-fat diet-induced obesity in mice. J Hypertens 28: 2111–2119, 2010.
85. Kruger H, Arias-Stella J. The placenta and the newborn infant at high altitudes. Am J Obstet Gynecol 106: 586–591, 1970.
86. Kueht ML, McFarlin BK, Lee RE. Severely obese have greater LPS-stimulated TNF-alpha production than normal weight African-American women. Obesity (Silver Spring) 17: 447–451, 2009.
87. Kuo JJ, Jones OB, Hall JE. Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin. Hypertension 37: 670–676, 2001.
88. LaMarca B, Parrish M, Ray LF, Murphy SR, Roberts L, Glover P, Wallukat G, Wenzel K, Cockrell K, Martin JN Jr, Ryan MJ, Dechend R. Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension 54: 905–909, 2009.
89. LaMarca B, Speed J, Fournier L, Babcock SA, Berry H, Cockrell K, Granger JP. Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade. Hypertension 52: 1161–1167, 2008.
90. LaMarca B, Wallace K, Herse F, Wallukat G, Martin JN Jr, Weimer Dechend R. Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes. Hypertension 57: 865–871, 2011.
91. LaMarca B, Wallukat G, Llinas M, Herse F, Dechend R, Granger JP. Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension 52: 1168–1172, 2008.
92. LaMarca BB, Bennett WA, Alexander BT, Cockrell K, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension 46: 1022–1025, 2005.
93. LaMarca BB, Cockrell K, Sullivan E, Bennett W, Granger JP. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension 46: 82–86, 2005.
94. Langford A, Joshu C, Chang JJ, Myles T, Leet T. Does gestational weight gain affect the risk of adverse maternal and infant outcomes in overweight women? Matern Child Health J 15: 860–865, 2011.
95. Lee H, Park H, Kim YJ, Kim HJ, Ahn YM, Park B, Park JH, Lee BE. Expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in human preeclamptic placenta: possible implications in the process of trophoblast apoptosis. Placenta 26: 226–233, 2005.
96. Liang C, DeCourcy K, Prater MR. High-saturated-fat diet induces gestational diabetes and placental vasculopathy in C57BL/6 mice. Metabolism 59: 943–950, 2010.
97. Liang CY, Wang LJ, Chen CP, Chen LF, Chen YH, Chen H. GCM1 regulation of the expression of syncytin 2 and its cognate receptor MFSD2A in human placenta. Biol Reprod 83: 387–395, 2010.
98. Liu H, Wu Y, Qiao F, Gong X. Effect of leptin on cytotrophoblast proliferation and invasion. J Huazhong Univ Sci Technolog Med Sci 29: 631–636, 2009.
99. Lobato NS, Neves KB, Filgueira FP, Fortes ZB, Carvalho MH, Webb RC, Oliveira AM, Tostes RC. The adipokine chemerin augments vascular reactivity to contractile stimuli via activation of the MEK-ERK1/2 pathway. Life Sci 91: 600–606, 2012.
100. Lorentzen B, Drevon CA, Endresen MJ, Henriksen T. Fatty acid pattern of esterified and free fatty acids in sera of women with normal and pre-eclamptic pregnancy. Br J Obstet Gynaecol 102: 530–537, 1995.
101. Macdonald-Wallis C, Tilling K, Fraser A, Nelson SM, Lawlor DA. Gestational weight gain as a risk factor for hypertensive disorders of pregnancy. Am J Obstet Gynecol 209: 327.e1–327.e17, 2013.
102. Maebayashi Asanuma A, Yamamoto T, Azuma H, Kato E, Yamamoto N, Murase T, Chishima F, Suzuki M. Expression of placenta growth factor, soluble fms-like tyrosine kinase-1, metal-responsive transcription factor-1, heme oxygenase 1 and hypoxia inducible factor-1alpha mRNAs in pre-eclampsia placenta and the effect of preeclampsia sera on their expression of choriocarcinoma cells. J Obstet Gynaecol Res 40: 2095–2103, 2014.
103. Magann EF, Doherty DA, Sandlin AT, Chauhan SP, Morrison JC. The effects of an increasing gradient of maternal obesity on pregnancy outcomes. Aust N Z J Obstet Gynaecol 53: 250–257, 2013.
104. Mao L, Zhou Q, Zhou S, Wilbur RR, Li X. Roles of apolipoprotein E (ApoE) and inducible nitric oxide synthase (iNOS) in inflammation and apoptosis in preeclampsia pathogenesis and progression. PLos One 8: e58168, 2013.
105. Margerison Zilko CE, Rehkopf D, Abrams B. Association of maternal gestational weight gain with short- and long-term maternal and child health outcomes. Am J Obstet Gynecol 202: 574 e571-e578, 2010.
106. Mariman EC, Wang P. Adipocyte extracellular matrix composition, dynamics and role in obesity. Cell Mol Life Sci 67: 1277–1292, 2010.
107. Martinez Abundis E, Gonzalez Ortiz M, Quinones Galvan A, Ferrannini E. Hyperinsulinemia in glucose-tolerant women with preeclampsia. A controlled study. Am J Hypertens 9: 610–614, 1996.
108. Masuyama H, Nobumoto E, Segawa T, Hiramatsu Y. Severe superimposed preeclampsia with obesity, diabetes and a mild imbalance of angiogenic factors. Acta Med Okayama 66: 171–175, 2012.
109. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649–658, 2003.
110. Mbah AK, Kornosky JL, Kristensen S, August EM, Alio AP, Marty PJ, Belogolovkin V, Bruder K, Salihu HM. Super-obesity and risk for early and late pre-eclampsia. BJOG 117: 997–1004, 2010.
111. McCarthy FP, Drewlo S, English FA, Kingdom J, Johns EJ, Kenny LC, Walsh SK. Evidence implicating peroxisome proliferator-activated receptor-gamma in the pathogenesis of preeclampsia. Hypertension 58: 882–887, 2011.
112. McDonald SD, Han Z, Mulla S, Beyene J, Knowledge Synthesis Group. Overweight and obesity in mothers and risk of preterm birth and low birth weight infants: systematic review and meta-analyses. BMJ 341: c3428, 2010.
113. McGuane JT, Danielson LA, Debrah JE, Rubin JP, Novak J, Conrad KP. Angiogenic growth factors are new and essential players in the sustained relaxin vasodilatory pathway in rodents and humans. Hypertension 57: 1151–1160, 2011.
114. Mendieta Zeron H, Garcia Solorio VJ, Nava Diaz PM, Garduno Alanis A, Santillan Benitez JG, Dominguez Garcia V, Escobar Briones C, Denova Gutierrez E. Hyperleptinemia as a prognostic factor for preeclampsia: a cohort study. Acta Medica 55: 165–171, 2012.
115. Mise H, Sagawa N, Matsumoto T, Yura S, Nanno H, Itoh H, Mori T, Masuzaki H, Hosoda K, Ogawa Y, Nakao K. Augmented placental production of leptin in preeclampsia: possible involvement of placental hypoxia. J Clin Endocrinol Metab 83: 3225–3229, 1998.
116. Moll SJ, Jones CJ, Crocker IP, Baker PN, Heazell AE. Epidermal growth factor rescues trophoblast apoptosis induced by reactive oxygen species. Apoptosis 12: 1611–1622, 2007.
117. Mundy AL, Haas E, Bhattacharya I, Widmer CC, Kretz M, Baumann K, Barton M. Endothelin stimulates vascular hydroxyl radical formation: effect of obesity. Am J Physiol Regul Integr Comp Physiol 293: R2218–R2224, 2007.
118. Murata M, Fukushima K, Takao T, Seki H, Takeda S, Wake N. Oxidative stress produced by xanthine oxidase induces apoptosis in human extravillous trophoblast cells. J Reproduct Dev 59: 7–13, 2013.
119. Murphy JG, Herrington JN, Granger JP, Khalil RA. Enhanced [Ca2+]i in renal arterial smooth muscle cells of pregnant rats with reduced uterine perfusion pressure. Am J Physiol Heart Circ Physiol 284: H393–H403, 2003.
120. Murphy SR, LaMarca B, Cockrell K, Arany M, Granger JP. L-arginine supplementation abolishes the blood pressure and endothelin response to chronic increases in plasma sFlt-1 in pregnant rats. Am J Physiol Regul Integr Comp Physiol 302: R259–R263, 2012.
121. Murphy SR, LaMarca BB, Cockrell K, Granger JP. Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats. Hypertension 55: 394–398, 2010.
122. Murphy SR, LaMarca BB, Parrish M, Cockrell K, Granger JP. Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-a. Am J Physiol Regul Integr Comp Physiol 304: R130–R135, 2013.
123. Nova A, Sibai BM, Barton JR, Mercer BM, Mitchell MD. Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol 165: 724–727, 1991.
124. Novotny SR, Wallace K, Heath J, Moseley J, Dhillon P, Weimer A, Wallukat G, Herse F, Wenzel K, Martin JN Jr, Dechend R, Lamarca Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats. Am J Physiol Regul Integr Comp Physiol 302: R1197–R1201, 2012.
125. Omole Ohonsi AaA, AO. Pre-eclampsia-a study of risk factors. AJOL 53: 99–102, 2008.
126. Palei A, Spradley FT, Granger JP. Chronic hyperleptinemia results in the development of hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol 308: R855–R861, 2015.
127. Palei AC, Spradley FT, Granger JP. Euglycemic hyperinsulinemia increases blood pressure in pregnant rats independent of placental anti-angiogenic and inflammatory factors. Am J Hypertens 26: 1445–1451, 2013.
128. Pardo F, Silva L, Saez T, Salsoso R, Gutierrez J, Sanhueza C, Leiva A, Sobrevia L. Human supraphysiological gestational weight gain and fetoplacental vascular dysfunction. Int J Obes (Lond) 39: 1264–1273, 2015.
129. Parrish MR, Murphy SR, Rutland S, Wallace K, Wenzel K, Wallukat G, Keiser S, Ray LF, Dechend R, Martin JN, Granger JP, LaMarca B. The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. Am J Hypertens 23: 911–916, 2010.
130. Pavan L, Hermouet A, Tsatsaris V, Therond P, Sawamura T, Evain-Brion D, Fournier T. Lipids from oxidized low-density lipoprotein modulate human trophoblast invasion: involvement of nuclear liver X receptors. Endocrinology 145: 4583–4591, 2004.
131. Peltier MR, Gurzenda EM, Murthy A, Chawala K, Lerner V, Kharode I, Arita Y, Rhodes A, Maari N, Moawad A, Hanna N. Can oxygen tension contribute to an abnormal placental cytokine milieu? Am J Reprod Immunol 66: 279–285, 2011.
132. Peralta C, Jimenez-Castro MB, Gracia-Sancho J. Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. J Hepatol 59: 1094–1106, 2013.
133. Perez-Sepulveda A, Torres MJ, Khoury M, Illanes SE. Innate immune system and preeclampsia. Front Immunol 5: 244, 2014.
134. Perlow JH, Morgan MA, Montgomery D, Towers CV, Porto M. Perinatal outcome in pregnancy complicated by massive obesity. Am J Obstet Gynecol 167: 958–962, 1992.
135. Podjarny E, Bernheim J, Katz B, Green J, Mekler J, Bursztyn M. Chronic exogenous hyperinsulinemia in pregnancy: a rat model of pregnancy-induced hypertension. J Am Soc Nephrol 9: 9–13, 1998.
136. Qiu C, Baylis C. Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition. Kidney Int 55: 2390–2396, 1999.
137. Radke AL, Reynolds LE, Melo RC, Dvorak AM, Weller PF, Spencer LA. Mature human eosinophils express functional Notch ligands mediating eosinophil autocrine regulation. Blood 113: 3092–3101, 2009.
138. Radulescu L, Munteanu O, Popa F, Cirstoiu M. The implications and consequences of maternal obesity on fetal intrauterine growth restriction. J Med Life 6: 292–298, 2013.
139. Rajakumar A, Doty K, Daftary A, Harger G, Conrad KP. Impaired oxygen-dependent reduction of HIF-1alpha and -2alpha proteins in preeclamptic placentae. Placenta 24: 199–208, 2003.
140. Rajasingam D, Seed PT, Briley AL, Shennan AH, Poston L. A prospective study of pregnancy outcome and biomarkers of oxidative stress in nulliparous obese women. Am J Obstet Gynecol 200: 395 e391-e399, 2009.
141. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 87: 4231–4237, 2002.
142. Rana S, Karumanchi SA, Lindheimer MD. Angiogenic factors in diagnosis, management, and research in preeclampsia. Hypertension 63: 198–202, 2014.
143. Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv 66: 497–506, 2011.
144. Redman CW, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol 63: 534–543, 2010.
145. Roberts JM, Bodnar LM, Patrick TE, Powers RW. The role of obesity in preeclampsia. Pregnancy Hypertens 1: 6–16, 2011.
146. Roberts KA, Riley SC, Reynolds RM, Barr S, Evans M, Statham A, Hor K, Jabbour HN, Norman JE, Denison FC. Placental structure and inflammation in pregnancies associated with obesity. Placenta 32: 247–254, 2011.
147. Roberts L, LaMarca BB, Fournier L, Bain J, Cockrell K, Granger JP. Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion. Hypertension 47: 615–618, 2006.
148. Robson A, Harris LK, Innes BA, Lash GE, Aljunaidy MM, Aplin JD, Baker PN, Robson SC, Bulmer JN. Uterine natural killer cells initiate spiral artery remodeling in human pregnancy. FASEB J 26: 4876–4885, 2012.
149. Rode L, Nilas L, Wojdemann K, Tabor A. Obesity-related complications in Danish single cephalic term pregnancies. Obstet Gynecol 105: 537–542, 2005.
150. Roldan M, Macias-Gonzalez M, Garcia R, Tinahones FJ, Martin M. Obesity short-circuits stemness gene network in human adipose multipotent stem cells. FASEB J 25: 4111–4126, 2011.
151. Russell Z, Salihu HM, Lynch O, Alio AP, Belogolovkin V. The association of prepregnancy body mass index with pregnancy outcomes in triplet gestations. Am J Perinatol 27: 41–46, 2010.
152. Rust OA, Bofill JA, Zappe DH, Hall JE, Burnett JC Jr, Martin JN, Jr. The origin of endothelin-1 in patients with severe preeclampsia. Obstet Gynecol 89: 754–757, 1997.
153. Saben J, Lindsey F, Zhong Y, Thakali K, Badger TM, Andres A, Gomez-Acevedo H, Shankar K. Maternal obesity is associated with a lipotoxic placental environment. Placenta 35: 171–177, 2014.
154. Sahin Z, Acar N, Ozbey O, Ustunel I, Demir R. Distribution of Notch family proteins in intrauterine growth restriction and hypertension complicated human term placentas. Acta Histochem 113: 270–276, 2011.
155. Schildroth J, Rettig-Zimmermann J, Kalk P, Steege A, Fahling M, Sendeski M, Paliege A, Lai EY, Bachmann S, Persson PB, Hocher B, Patzak A. Endothelin type A and B receptors in the control of afferent and efferent arterioles in mice. Nephrol Dial Transplant 26: 779–789, 2011.
156. Schonkeren D, van der Hoorn ML, Khedoe P, Swings G, van Beelen E, Claas F, van Kooten C, de Heer E, Scherjon S. Differential distribution and phenotype of decidual macrophages in preeclamptic versus control pregnancies. Am J Pathol 178: 709–717, 2011.
157. Shah D, Frazer M, Badr KF. Circulating endothelin-1 is not increased in severe preeclampsia. J Maternal Fetal Neonatal Med 1: 177–180, 1992.
158. Shah TJ, Leik CE, Walsh SW. Neutrophil infiltration and systemic vascular inflammation in obese women. Reprod Sci 17: 116–124, 2010.
159. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension 31: 409–414, 1998.
160. Shen H, Liu H, Chen H, Guo Y, Zhang M, Xu X, Xiang W. Analysis of placental growth factor in placentas of normal pregnant women and women with hypertensive disorders of pregnancy. J Huazhong Univ Sci Technolog Med Sci 26: 116–119, 2006.
161. Shi Z, Brooks VL. Leptin differentially increases sympathetic nerve activity and its baroreflex regulation in female rats: role of estrogen. J Physiol 593: 1633–1647, 2014.
162. Shigematsu K, Nakatani A, Kawai K, Moriuchi R, Katamine S, Miyamoto T, Niwa M. Two subtypes of endothelin receptors and endothelin peptides are expressed in differential cell types of the rat placenta: in vitro receptor autoradiographic and in situ hybridization studies. Endocrinology 137: 738–748, 1996.
163. Sibley CP, Pardi G, Cetin I, Todros T, Piccoli E, Kaufmann P, Huppertz B, Bulfamante G, Cribiu FM, Ayuk P, Glazier J, Radaelli T. Pathogenesis of intrauterine growth restriction (IUGR)-conclusions derived from a European Union Biomed 2 Concerted Action project “Importance of Oxygen Supply in Intrauterine Growth Restricted Pregnancies” workshop report. Placenta 23, Suppl A: S75–S79, 2002.
164. Siegmund B, Sennello JA, Jones-Carson J, Gamboni-Robertson F, Lehr HA, Batra A, Fedke I, Zeitz M, Fantuzzi G. Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice. Gut 53: 965–972, 2004.
165. Sisino G, Bouckenooghe T, Aurientis S, Fontaine P, Storme L, Vambergue A. Diabetes during pregnancy influences Hofbauer cells, a subtype of placental macrophages, to acquire a pro-inflammatory phenotype. Biochim Biophys Acta 1832: 1959–1968, 2013.
166. Sivakumar K, Bari MF, Adaikalakoteswari A, Guller S, Weickert MO, Randeva HS, Grammatopoulos DK, Bastie CC, Vatish M. Elevated fetal adipsin/acylation-stimulating protein (ASP) in obese pregnancy: novel placental secretion via Hofbauer cells. J Clin Endocrinol Metab 98: 4113–4122, 2013.
167. Skarzinski G, Khamaisi M, Bursztyn M, Mekler J, Lan D, Evdokimov P, Ariel I. Intrauterine growth restriction and shallower implantation site in rats with maternal hyperinsulinemia are associated with altered NOS expression. Placenta 30: 898–906, 2009.
168. Solomon CG, Carroll JS, Okamura K, Graves SW, Seely EW. Higher cholesterol and insulin levels in pregnancy are associated with increased risk for pregnancy-induced hypertension. Am J Hypertens 12: 276–282, 1999.
169. Soma H, Yoshida K, Mukaida T, Tabuchi Y. Morphologic changes in the hypertensive placenta. Contrib Gynecol Obstet 9: 58–75, 1982.
170. Spradley FT, Palei AC, Granger JP. Obese melanocortin-4 receptordeficient rats exhibit augmented angiogenic balance and vasorelaxation during pregnancy. Physiol Reports 1: e00081, 2013.
171. Stepan H, Philipp A, Roth I, Kralisch S, Jank A, Schaarschmidt W, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M. Serum levels of the adipokine chemerin are increased in preeclampsia during and 6 months after pregnancy. Regul Pept 168: 69–72, 2011.
172. Stewart FM, Freeman DJ, Ramsay JE, Greer IA, Caslake M, Ferrell WR. Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab 92: 969–975, 2007.
173. Straughen JK, Misra DP, Kumar P, Misra VK. The influence of overweight and obesity on maternal soluble fms-like tyrosine kinase 1 and its relationship with leptin during pregnancy. Reprod Sci 20: 269–275, 2013.
174. Tache V, Ciric A, Moretto Zita M, Li Y, Peng J, Maltepe E, Milstone DS, Parast M. Hypoxia and trophoblast differentiation: a key role for PPARgamma. Stem Cells Dev 22: 2815–2824, 2013.
175. Tal R, Shaish A, Barshack I, Polak-Charcon S, Afek A, Volkov A, Feldman B, Avivi C, Harats D. Effects of hypoxia-inducible factor-1α overexpression in pregnant mice: possible implications for preeclampsia and intrauterine growth restriction. Am J Pathol 177: 2950–2962, 2010.
176. Tam Tam KB, George E, Cockrell K, Arany M, Speed J, Martin JN Jr, Lamarca B, Granger JP. Endothelin type A receptor antagonist attenuates placental ischemia-induced hypertension and uterine vascular resistance. Am J Obstet Gynecol 204: 330 e331-e334, 2011.
177. Tam Tam KB, Lamarca B, Arany M, Cockrell K, Fournier L, Murphy S, Martin JN Jr, Granger JP. Role of reactive oxygen species during hypertension in response to chronic antiangiogenic factor (sFlt-1) excess in pregnant rats. Am J Hypertens 24: 110–113, 2011.
178. Tanoue Y, Herijgers P, Meuris B, Verbeken E, Leunens V, Lox M, Flameng W. Ischemic preconditioning reduces unloaded myocardial oxygen consumption in an in-vivo sheep model. Cardiovasc Res 55: 633–641, 2002.
179. Tavana TZ, J; Madadi G. The relationship between maternal serum highly sensitive C-reactive protein, leptin and hypertensive disorders of pregnancy. Internet J Endocrinol 6: 1, 2011.
180. Tracy TA, Miller GL. Obstetric problems of the massively obese. Obstet Gynecol 33: 204–208, 1969.
181. Valsamakis G, Kumar S, Creatsas G, Mastorakos G. The effects of adipose tissue and adipocytokines in human pregnancy. Ann NY Acad Sci 1205: 76–81, 2010.
182. van Drongelen J, van Koppen A, Pertijs J, Gooi JH, Parry LJ, Sweep FC, Lotgering FK, Smits P, Spaanderman ME. Impaired vascular responses to relaxin in diet-induced overweight female rats. J Appl Physiol 112: 962–969, 2012.
183. Verlohren S, Geusens N, Morton J, Verhaegen I, Hering L, Herse F, Dudenhausen JW, Muller DN, Luft FC, Cartwright JE, Davidge ST, Pijnenborg R, Dechend R. Inhibition of trophoblast-induced spiral artery remodeling reduces placental perfusion in rat pregnancy. Hypertension 56: 304–310, 2010.
184. von Versen-Hoeynck FM, Powers RW. Maternal-fetal metabolism in normal pregnancy and preeclampsia. Front Biosci 12: 2457–2470, 2007.
185. Vrijkotte TG, Krukziener N, Hutten BA, Vollebregt KC, van Eijsden M, Twickler MB. Maternal lipid profile during early pregnancy and pregnancy complications and outcomes: the ABCD study. J Clin EndocrinolMetab 97: 3917–3925, 2012.
186. Wallace JM, Horgan GW, Bhattacharya S. Placental weight and efficiency in relation to maternal body mass index and the risk of pregnancy complications in women delivering singleton babies. Placenta 33: 611–618, 2012.
187. Wallace K, Richards S, Dhillon P, Weimer A, Edholm ES, Bengten E, Wilson M, Martin JN Jr, LaMarca B. CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy. Hypertension 57: 949–955, 2011.
188. Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987–2004. Am J Hypertens 21: 521–526, 2008.
189. Wang T, Zhou R, Gao L, Wang Y, Song C, Gong Y, Jia J, Xiong W, Dai L, Zhang L, Hu H. Elevation of urinary adipsin in preeclampsia: correlation with urine protein concentration and the potential use for a rapid diagnostic test. Hypertension 64: 846–851, 2014.
190. Wang Y, Walsh SW. TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol 32: 157–169, 1996.
191. Warrington JP, George EM, Palei AC, Spradley FT, Granger JP. Recent advances in the understanding of the pathophysiology of preeclampsia. Hypertension 62: 666–673, 2013.
192. Weed S, Bastek JA, Anton L, Elovitz MA, Parry S, Srinivas SK. Examining the correlation between placental and serum placenta growth factor in preeclampsia. Am J Obstet Gynecol 207: 140.e1–140.e6, 2012.
193. Weil BR, Westby CM, Van Guilder GP, Greiner JJ, Stauffer BL, DeSouza CA. Enhanced endothelin-1 system activity with overweight and obesity. Am J Physiol Heart Circ Physiol 301: H689–H695, 2011.
194. Weisbrod RM, Griswold MC, Du Y, Bolotina VM, Cohen RA. Reduced responsiveness of hypercholesterolemic rabbit aortic smooth muscle cells to nitric oxide. Arterioscler Thromb Vasc Biol 17: 394–402, 1997.
195. Weiss HR, Grayson J, Liu X, Barsoum S, Shah H, Chi OZ. Cerebral ischemia and reperfusion increases the heterogeneity of local oxygen supply/consumption balance. Stroke 44: 2553–2558, 2013.
196. Wermter AK, Scherag A, Meyre D, Reichwald K, Durand E, Nguyen TT, Koberwitz K, Lichtner P, Meitinger T, Schafer H, Hinney A, Froguel P, Hebebrand J, Bronner G. Preferential reciprocal transfer of paternal/maternal DLK1 alleles to obese children: first evidence of polar overdominance in humans. Eur J Hum Genet 16: 1126–1134, 2008.
197. Whitley GS, Dash PR, Ayling LJ, Prefumo F, Thilaganathan B, Cartwright JE. Increased apoptosis in first trimester extravillous trophoblasts from pregnancies at higher risk of developing preeclampsia. Am J Pathol 170: 1903–1909, 2007.
198. Wyrwoll CS, Mark PJ, Waddell BJ. Directional secretion and transport of leptin and expression of leptin receptor isoforms in human placental BeWo cells. Mol Cell Endocrinol 241: 73–79, 2005.
199. Yu X, Yang Z, Yu M. Correlation of tumor necrosis factor alpha and interleukin 6 with hypertensive renal damage. Ren Fail 32: 475–479, 2010.
200. Yu Z, Han S, Zhu J, Sun X, Ji C, Guo X. Pre-pregnancy body mass index in relation to infant birth weight and offspring overweight/obesity: a systematic review and meta-analysis. PLos One 8: e61627, 2013.
201. Zeck W, Widberg C, Maylin E, Desoye G, Lang U, McIntyre D, Prins J, Russell A. Regulation of placental growth hormone secretion in a human trophoblast model-the effects of hormones and adipokines. Pediatr Res 63: 353–357, 2008.